Who should a patient with abnormal von Willebrand (VWD) disease be referred to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Referral for Abnormal von Willebrand Disease

Patients with abnormal von Willebrand disease should be referred to a hematologist, preferably one with expertise in bleeding disorders or at a hemophilia treatment center. 1

Understanding von Willebrand Disease

Von Willebrand disease (VWD) is the most common inherited bleeding disorder, affecting approximately 1% of the general population. It results from deficiency or dysfunction of von Willebrand factor (VWF), a multimeric plasma glycoprotein that:

  • Mediates platelet adhesion and aggregation at sites of vascular injury
  • Carries and stabilizes blood coagulation factor VIII in circulation 2

Types of VWD

  • Type 1: Partial quantitative deficiency (~75% of cases)
  • Type 2: Qualitative deficiency with four subtypes (2A, 2B, 2M, 2N)
  • Type 3: Virtually complete quantitative deficiency (rare, ~1 in 1,000)
  • Acquired von Willebrand Syndrome (AVWS): Associated with various medical conditions 2

Diagnostic Process Before Referral

Primary care physicians should initiate the evaluation when VWD is suspected:

  1. Clinical assessment:

    • Document frequency and severity of bleeding episodes
    • Look for easy bruising, nosebleeds, mucosal bleeding, gastrointestinal bleeding
    • In women, assess for heavy menstrual bleeding (affects 5-20% of women with menorrhagia) 1
    • Review family history for bleeding disorders 3
  2. Initial laboratory tests:

    • Complete blood count (CBC)
    • Prothrombin time (PT)
    • Activated partial thromboplastin time (PTT) 3
  3. Core VWD tests for patients with mucocutaneous bleeding history:

    • VWF antigen (VWF:Ag)
    • VWF ristocetin cofactor activity (VWF:RCo)
    • Factor VIII coagulant activity (FVIII) 3

When to Refer to a Hematologist

Referral to a hematologist is indicated when:

  • Abnormal VWF test results are present
  • Patient has significant bleeding symptoms
  • There is a strong family history of VWD 3

Specialized Care by Hematologists

Hematologists with expertise in bleeding disorders provide:

  1. Definitive diagnosis:

    • Specialized laboratory testing to determine VWD type and subtype
    • Calculation of VWF:RCo to VWF:Ag ratio (ratio <0.5-0.7 suggests Type 2 VWD)
    • Repeat testing (VWF levels can vary and may need to be tested up to 3 times) 3
    • Genetic testing for confirmation of type 2 subtypes and type 3 VWD 4
  2. Treatment planning:

    • First-line treatment selection (desmopressin vs. factor concentrates)
    • Desmopressin for mild to moderate Type 1 VWD
    • VWF-containing factor concentrates for Type 2B, Type 3, and severe forms of Type 1 and 2 3, 5
    • Antifibrinolytic medications for minor procedures 1
  3. Special considerations:

    • Management during pregnancy and childbirth
    • Surgical planning and perioperative care
    • Prophylaxis for patients with recurrent joint bleeding 6

Hemophilia Treatment Centers

For optimal care, referral to a hemophilia treatment center (HTC) is recommended, especially for:

  • Complex cases
  • Major surgeries
  • Childbirth management
  • Patients with severe disease 1

HTCs provide comprehensive care with experienced:

  • Hematologists
  • Anesthesiologists
  • Pharmacists
  • Laboratory support 1

Special Considerations for Women

Women with VWD require specialized care for:

  • Heavy menstrual bleeding management
  • Pregnancy planning
  • Childbirth (risk of postpartum hemorrhage)
  • Interdisciplinary management with gynecologists/obstetricians 7

Pitfalls to Avoid

  • Delayed diagnosis: VWD is often underdiagnosed, particularly in women with menorrhagia
  • Inadequate testing: Single VWF tests may be insufficient due to variability in levels
  • Inappropriate treatment: Using desmopressin in Type 2B VWD can cause thrombosis 5
  • Failure to monitor sodium levels: Desmopressin can cause hyponatremia 5
  • Inadequate perioperative planning: Major surgeries require specialized management

Remember that von Willebrand disease is a lifelong condition requiring ongoing specialized care. Early referral to a hematologist with expertise in bleeding disorders ensures proper diagnosis, treatment, and management of this complex condition.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bleeding Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and treatment of von Willebrand disease in 2024 and beyond.

Haemophilia : the official journal of the World Federation of Hemophilia, 2024

Research

Prophylaxis and von Willebrand's disease (vWD).

Thrombosis research, 2006

Research

von Willebrand disease: Diagnosis and treatment, treatment of women, and genomic approach to diagnosis.

Haemophilia : the official journal of the World Federation of Hemophilia, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.